Cargando…

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related deaths worldwide. Copy number variations (CNVs) affect the expression of genes and play critical roles in carcinogenesis. We aimed to identify specific CNV-driven genes and establish a prognostic model for HCC. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Jin, Long, Junyu, Yang, Xu, Yang, Xiaobo, Xu, Yiyao, Lu, Xin, Guan, Mei, Sang, Xinting, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246234/ https://www.ncbi.nlm.nih.gov/pubmed/34268378 http://dx.doi.org/10.21037/atm-20-7101

Ejemplares similares

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma
por: Zuo, Bangyou, et al.
Publicado: (2022)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2019)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Safety, feasibility, and efficacy of associating liver partition and portal vein ligation for staged hepatectomy in treating hepatocellular carcinoma: a systematic review
por: Zhang, Junwei, et al.
Publicado: (2020)

Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma
por: Sun, Huishan, et al.
Publicado: (2023)

Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes
por: Han, Chunjiao, et al.
Publicado: (2022)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)

Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma
por: Xiong, Jianping, et al.
Publicado: (2017)

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma
por: Xun, Ziyu, et al.
Publicado: (2023)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

Immunotherapy prototype Mark 3.0 model in primary liver cancer: adding locoregional stereotactic therapy and prognostic factors classification management
por: Yang, Xu, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing
por: Zheng, Yongchang, et al.
Publicado: (2017)

Association of chronic liver disease with the prognosis of COVID-19 patients
por: Long, Junyu, et al.
Publicado: (2022)

Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer
por: Hu, Wei, et al.
Publicado: (2021)

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
por: Wang, Dongxu, et al.
Publicado: (2019)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
por: Huang, Hanchun, et al.
Publicado: (2019)

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
por: Yang, Xu, et al.
Publicado: (2023)

Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression
por: Bai, Yi, et al.
Publicado: (2019)

Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes
por: Wang, Lei, et al.
Publicado: (2022)

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
por: Long, Junyu, et al.
Publicado: (2021)

An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation
por: Feng, Rui, et al.
Publicado: (2021)

Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma
por: Peng, Yue-ling, et al.
Publicado: (2023)

Apatinib as non-first-line treatment in patients with Intrahepatic Cholangiocarcinoma
por: Mao, Jinzhu, et al.
Publicado: (2021)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n4lv6qdh5i4nr74tgs0p9hof3e